HIV Vaccination and Immunotherapy JP

Country:
Japan

Docket No:
436313-000410

Publication Number:
7153332

Patent Expiry:
01/11/2037

Claims Scope:

Patent issued October 5, 2022. 

 

Composition and methods for producing HIV-resistant cells and inhibiting HIV infection in HIV negative individuals; reciting 90% identity to SEQ ID NO: 31 (Vif, Tat, and CCR5); or 90% identity to SEQ ID NO: 2 (Vif guide plus backbone) and SEQ ID NO: 108 (Tat guide plus backbone).